Synthesis of R- and S-MDMA via nucleophilic ring-opening of homochiral N-tosylaziridines
Katie D. Lewis, Glenn A. Pullella, Han Chern Loh, Brian W. Skelton, Gavin R. Flematti, Matthew Piggott
Australian Journal of Chemistry July 11, 2023 DOI: 10.1071/ch23064 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Synthetic methodology paper Peer reviewed |
|---|---|
| Topics | MDMA |
| Keywords | Regioselectivity Enantioselective synthesis Enantiomer Ring chemistry Biocatalysis Nucleophilic substitution Reagent Nucleophile Stereochemistry Medicinal chemistry Organic chemistry Reaction mechanism Alkaloids |
| Citations | 2 |
| Key points | Homochiral R- and S-MDMA were prepared with >99.5% enantiopurity via a copper-catalyzed regioselective ring-opening of an N-tosylaziridine, but the same method failed for the α-phenyl analogue UWA-001 due to a regioselectivity switch. |
Abstract
Homochiral (R)- and (S)-3,4-methylenedioxymethamphetamine (MDMA) were prepared in six steps (each) from the chiral pool precursors d- and l-alanine, respectively. The key step, copper-catalysed regioselective ring-opening of an N-tosylaziridine with an aryl Grignard reagent, proceeded in high yield with complete regioselectivity. Elaboration was achieved with preservation of configurational integrity, affording R- and S-MDMA hydrochlorides with enantiopurities of >99.5%, as determined by enantioselective HPLC with fluorescence detection. Attempts to apply the synthetic methodology to the synthesis of the homochiral enantiomers of the a-phenyl analogue of MDMA (UWA-001) were thwarted by a switch in regioselectivity in the key step.
Citations in the library
Cites 39
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine June 1, 2021
- Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology November 1, 2018
- The Background and Chemistry of MDMA Journal of Psychoactive Drugs October 1, 1986
- The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents* Addiction July 8, 2006
- Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class Journal of Medicinal Chemistry October 1, 1986
and 34 more in the library